Finepoint Capital LP

Investment Portfolio & 13F Holdings Analysis

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-14
Total Holdings
25
Total Value
1311243830
Accession Number
0000904454-25-000272
Form Type
13F-HR
Manager Name
Finepoint-Capital-Lp
Data Enrichment
84% identified
21 identified4 unidentified

Holdings

25 positions
Manager:
Search and click to pin securities to the top
Page 1 of 2
SPDR S&P 500 ETF TRUST
Shares:755.0K
Value:$422.2M
QXO, Inc.
Shares:24.5M
Value:$331.3M
464287655
Shares:1.5M
Value:$296.3M
Liberty Broadband Corp
Shares:529.2K
Value:$45.0M
SpringWorks Therapeutics, Inc.
Shares:728.6K
Value:$32.2M
Liberty Media Corp
Shares:432.9K
Value:$29.5M
Ascendis Pharma A/S
Shares:179.9K
Value:$28.0M
Revolution Medicines, Inc.
Shares:691.3K
Value:$24.4M
MoonLake Immunotherapeutics
Shares:435.8K
Value:$17.0M
GALAPAGOS NV
Shares:656.6K
Value:$16.5M
CYTOKINETICS INC
Shares:309.9K
Value:$12.5M
Avidity Biosciences, Inc.
Shares:380.7K
Value:$11.2M
Sarepta Therapeutics, Inc.
Shares:157.6K
Value:$10.1M
PROTHENA CORP PUBLIC LTD CO
Shares:640.1K
Value:$7.9M
Xencor Inc
Shares:642.2K
Value:$6.8M
EyePoint Pharmaceuticals, Inc.
Shares:1.1M
Value:$5.9M
Relay Therapeutics, Inc.
Shares:2.1M
Value:$5.5M
ARVINAS, INC.
Shares:694.0K
Value:$4.9M
Solid Biosciences Inc.
Shares:961.3K
Value:$3.6M
01444V103
Shares:27.7K
Value:$208.7K